Madison Wealth Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,316
Closed -$337K 224
2025
Q4
$337K Sell
3,316
-891
-21% -$71.6K 0.06% 139
2025
Q3
$230K Sell
4,207
-62
-1% -$3.1K 0.05% 156
2025
Q2
$227K Buy
+4,269
New +$217K 0.05% 154
2025
Q1
Sell
-4,117
Closed -$231K 160
2024
Q4
$231K Buy
4,117
+130
+3% +$8.09K 0.06% 137
2024
Q3
$272K Buy
+3,987
New +$225K 0.08% 122
2024
Q2
Sell
-3,609
Closed -$249K 129
2024
Q1
$249K Sell
3,609
-45
-1% -$2.85K 0.09% 107
2023
Q4
$270K Buy
3,654
+20
+0.6% +$1.31K 0.11% 99
2023
Q3
$248K Buy
3,634
+200
+6% +$17K 0.13% 76
2023
Q2
$322K Hold
3,434
0.15% 63
2023
Q1
$233K Buy
+3,434
New +$221K 0.12% 77

Other funds holding EXAS

Madison Wealth Partners's EXAS Position: Q1 2026 in Review

Madison Wealth Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,316 shares — an estimated $337K sold.

Madison Wealth Partners first reported a position in EXAS in Q1 2023 and held it in 10 quarters. The position peaked at $337K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Madison Wealth Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Madison Wealth Partners sold 3,316 Exact Sciences shares in Q1 2026, an estimated $337K.
  • Madison Wealth Partners first reported a position in Exact Sciences in Q1 2023 and held it in 10 quarters.
  • Madison Wealth Partners's Exact Sciences position peaked at $337K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Madison Wealth Partners's 13F filing for Q1 2026, filed 30 Apr 2026.